Literature DB >> 26759438

Somatic symptom disorder, a new DSM-5 diagnosis of an old clinical challenge.

Tea Rosic1, Sameer Kalra1, Zainab Samaan2.   

Abstract

Somatic symptom disorder (SSD) is characterised by a dysfunctional preoccupation with one or more physical symptoms. Patients with SSD often pursue excessive and unnecessary investigations, hospitalisations and treatments that significantly affect quality of life and drain healthcare resources. Thus, appropriate diagnosis and careful management are required to mitigate the patient's distress and to reduce the burden to the healthcare system. SSD is a new disorder defined in the Diagnostic and Statistical Manual Fifth Edition (DSM-5), replacing somatoform and related disorders in the DSM-4-Text Revision with diagnostic criteria that are inclusive of a broad array of presentations. This report presents a detailed clinical case of an elderly man with a history of frequent hospital visits presenting with SSD. We discuss diagnostic challenges and evidence-based management in acute inpatient as well as in outpatient settings. We also review data on healthcare utilisation associated with SSD. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 26759438      PMCID: PMC4716311          DOI: 10.1136/bcr-2015-212553

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  27 in total

1.  Hypochondriasis and ECT.

Authors:  Thomas S Newmark; Sadiq Al-Samarrai
Journal:  Psychosomatics       Date:  2004 Jan-Feb       Impact factor: 2.386

Review 2.  Effect of alexithymia on the process and outcome of psychotherapy: a programmatic review.

Authors:  John S Ogrodniczuk; William E Piper; Anthony S Joyce
Journal:  Psychiatry Res       Date:  2010-05-14       Impact factor: 3.222

3.  Somatic symptom disorder: an important change in DSM.

Authors:  Joel E Dimsdale; Francis Creed; Javier Escobar; Michael Sharpe; Lawson Wulsin; Arthur Barsky; Sing Lee; Michael R Irwin; James Levenson
Journal:  J Psychosom Res       Date:  2013-07-25       Impact factor: 3.006

4.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

5.  Medically unexplained symptoms: a treacherous foundation for somatoform disorders?

Authors:  Joel E Dimsdale
Journal:  Psychiatr Clin North Am       Date:  2011-07-23

6.  St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.

Authors:  Hans-Peter Volz; Harald Murck; Siegfried Kasper; Hans-Jürgen Möller
Journal:  Psychopharmacology (Berl)       Date:  2002-07-17       Impact factor: 4.530

Review 7.  Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management.

Authors:  Kurt Kroenke
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

8.  A systematic review of the epidemiology of somatisation disorder and hypochondriasis.

Authors:  Francis Creed; Arthur Barsky
Journal:  J Psychosom Res       Date:  2004-04       Impact factor: 3.006

9.  The effect of mirtazapine in patients with chronic pain and concomitant depression.

Authors:  R Freynhagen; U Muth-Selbach; P Lipfert; M F Stevens; K Zacharowski; T R Tölle; H-J von Giesen
Journal:  Curr Med Res Opin       Date:  2006-02       Impact factor: 2.580

Review 10.  Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.

Authors:  Michael P T Lunn; Richard A C Hughes; Philip J Wiffen
Journal:  Cochrane Database Syst Rev       Date:  2014-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.